Polymorphisms of TP53 codon 72 with breast carcinoma risk: evidence from 12226 cases and 10782 controls

scientific article published on 14 August 2009

Polymorphisms of TP53 codon 72 with breast carcinoma risk: evidence from 12226 cases and 10782 controls is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1053299129
P356DOI10.1186/1756-9966-28-115
P932PMC publication ID3225858
P698PubMed publication ID19682377
P5875ResearchGate publication ID26743586

P2093author name stringLei Cai
Zhengtang Chen
Yunsong Zhang
Wenlei Zhuo
Zhaolan Xiang
P2860cites workBias in meta-analysis detected by a simple, graphical testQ24685585
TP53 polymorphisms and lung cancer risk: a systematic review and meta-analysisQ27824797
Do MDM2 SNP309 and TP53 R72P interact in breast cancer susceptibility? A large pooled series from the breast cancer association consortiumQ27851413
Cytochrome P-450 1A1 gene polymorphisms and risk of breast cancer: a HuGE reviewQ28248473
Cancer statistics, 2007Q29547293
Importance of TP53 codon 72 and intron 3 duplication 16bp polymorphisms in prediction of susceptibility on breast cancerQ33317092
Association of the germline TP53 R337H mutation with breast cancer in southern BrazilQ33388533
Persistent human papillomavirus infection and cervical neoplasia: a systematic review and meta-analysisQ33883532
Human papillomavirus as a risk factor for oral squamous cell carcinoma: a meta-analysis, 1982-1997.Q34279292
Oral contraceptive use as a risk factor for premenopausal breast cancer: a meta-analysisQ34573557
Polymorphisms of H-ras-1 and p53 in breast cancer and lung cancer: a meta-analysisQ34638831
p53 codon 72 polymorphism and cervical neoplasia: a meta-analysis reviewQ35639506
Polymorphism p53 codon-72 and invasive cervical cancer: a meta-analysisQ35774090
Common variants in the ATM, BRCA1, BRCA2, CHEK2 and TP53 cancer susceptibility genes are unlikely to increase breast cancer riskQ35794359
Association of TP53 codon 72 polymorphism and the outcome of adjuvant therapy in breast cancer patientsQ35906322
Estrogen receptor alpha polymorphisms and postmenopausal breast cancer riskQ36412900
Polymorphisms in the p53 pathway.Q36426763
Implication of BRCA2 -26G>A 5' untranslated region polymorphism in susceptibility to sporadic breast cancer and its modulation by p53 codon 72 Arg>Pro polymorphismQ36458780
The R72P P53 mutation is associated with familial breast cancer in Jewish womenQ36616536
Obesity and prognosis of breast cancerQ36622232
P53 codon 72 polymorphism and gastric cancer: a meta-analysis of the literatureQ36839254
Is the p53 codon 72 polymorphism a key biomarker for cervical cancer development? A meta-analysis review within European populations.Q36958899
Insulin, insulin-like growth factor-I, and risk of breast cancer in postmenopausal womenQ37090766
The possible involvement of virus in breast cancerQ37325562
Association of p53 codon Arg72Pro and p73 G4C14-to-A4T14 at exon 2 genetic polymorphisms with the risk of Japanese breast cancer.Q38347647
No evidence of correlation between p53 codon 72 polymorphism and risk of bladder or breast carcinoma in Tunisian patientsQ39199067
Role of p53 codon 72 arginine allele in cell survival in vitro and in the clinical outcome of patients with advanced breast cancerQ39963569
Assessing publication bias in genetic association studies: evidence from a recent meta-analysis.Q40464249
Codon 72 polymorphism of the TP53 geneQ40522948
Retention of the p53 codon 72 arginine allele is associated with a reduction of disease-free and overall survival in arginine/proline heterozygous breast cancer patientsQ40622483
The codon 72 polymorphic variants of p53 have markedly different apoptotic potentialQ40672888
Expression of the mutated p53 tumor suppressor protein and its molecular and biochemical characterization in multidrug resistant MCF-7/Adr human breast cancer cellsQ41132525
Family history and the risk of breast cancer: a systematic review and meta-analysisQ41495151
A meta-analysis of TP53 codon 72 polymorphism and lung cancer risk: evidence from 15,857 subjectsQ43552748
The proline form of p53 codon 72 polymorphism is associated with endometriosisQ43846887
The TP53 codon 72 polymorphism may affect the function of TP53 mutations in breast carcinomas but not in colorectal carcinomas.Q44258889
p53 codon 72 polymorphism (C/G) and the risk of human papillomavirus-associated carcinomas in ChinaQ44299674
Possible difference in frequencies of genetic polymorphisms of estrogen receptor alpha, estrogen metabolism and P53 genes between estrogen receptor-positive and -negative breast cancersQ44325520
P53 codon 72 polymorphism in breast cancerQ44396389
Polymorphism of the p53 codon 72 Arg/Pro and the risk of HPV type 16/18-associated cervical and oral cancer in India.Q44631153
P53 codon 72 polymorphism and risk of gastric cancer in a Chinese populationQ44834112
Association of p53 genetic polymorphism (Arg72Pro) with estrogen receptor positive breast cancer risk in Japanese womenQ44926364
Study of p53 codon 72 polymorphism in patients with breast cancerQ45223841
Fok1 polymorphism of vitamin D receptor gene contributes to breast cancer susceptibility: a meta-analysisQ46162058
Analysis of p53 gene polymorphisms and protein over-expression in patients with breast cancer.Q46219855
The association of p53 mutations and p53 codon 72, Her 2 codon 655 and MTHFR C677T polymorphisms with breast cancer in Northern GreeceQ46443444
Breast cancer patients with p53 Pro72 homozygous genotype have a poorer survivalQ46610600
Evidence for selective expression of the p53 codon 72 polymorphs: implications in cancer developmentQ46711410
MDM2 SNP309 G allele increases risk but the T allele is associated with earlier onset age of sporadic breast cancers in the Chinese populationQ46748574
p53 Codon 72 polymorphism predicts the pathologic response to neoadjuvant chemotherapy in patients with breast cancerQ46769388
Association of p53 polymorphisms and its haplotypes with susceptibility of breast cancerQ46860143
Role of a p53 polymorphism in the development of human papillomavirus-associated cancerQ48024470
Polymorphism of TP53 codon 72 showed no association with breast cancer in Iranian women.Q51767667
Evidence for an association of TP53 codon 72 polymorphism with breast cancer risk.Q51776297
Meta-analysis of genetic association studies.Q52966223
Genetic variation in TP53 and risk of breast cancer in a population-based case control study.Q53334287
Genetic polymorphisms in base-excision repair pathway genes and risk of breast cancer.Q53349070
p53 haplotype determination in breast cancer.Q53446391
p53 polymorphisms and haplotypes in breast cancer.Q53454066
Polymorphisms of the TP53 codon 72 and WRN codon 1367 in individuals from Northern Brazil with gastric adenocarcinoma.Q54626326
P53 mutations in colorectal cancer from northern Iran: Relationships with site of tumor origin, microsatellite instability and K-ras mutationsQ57157305
LOH rather than genotypes ofTP53codon 72 is associated with disease-free survival in primary breast cancerQ58213042
p53 codon 72 polymorphism as a risk factor in the development of breast cancerQ73080758
A p53 genetic polymorphism as a modulator of hepatocellular carcinoma risk in relation to chronic liver disease, familial tendency, and cigarette smoking in hepatitis B carriersQ74529921
Intron 3 16 bp duplication polymorphism of p53 is associated with an increased risk for breast cancer by the age of 50 yearsQ77858499
Prognostic significance of p53 codon 72 polymorphism in lung carcinomasQ78128600
Polymorphism of XRCC1 (at codon 399) and susceptibility to breast cancer, a meta-analysis of the literaturesQ81280245
TP53 gene mutations of lung cancer patients in upper northern Thailand and environmental risk factorsQ81701810
Methylenetetrahydrofolate reductase gene and susceptibility to breast cancer: a meta-analysisQ83185623
P275copyright licenseCreative Commons Attribution 2.0 GenericQ19125117
P6216copyright statuscopyrightedQ50423863
P921main subjectbreast carcinomaQ18555947
P304page(s)115
P577publication date2009-08-14
P1433published inJournal of Experimental & Clinical Cancer ResearchQ13739415
P1476titlePolymorphisms of TP53 codon 72 with breast carcinoma risk: evidence from 12226 cases and 10782 controls
P478volume28

Reverse relations

cites work (P2860)
Q82288012A small number of subjects do not always indicate that they are minor variants data for inclusion in a pooled analysis
Q33766324Assessment of changes in the BRCA2 and P53 genes in breast invasive ductal carcinoma in northeast Brazil.
Q33597618Association between polymorphisms in TP53 and MDM2 genes and susceptibility to prostate cancer
Q60934669Association of Single-Nucleotide Polymorphisms in Monoubiquitinated FANCD2-DNA Damage Repair Pathway Genes With Breast Cancer in the Chinese Population
Q58002983Association of TP53 mutations with TP53 codon 72 polymorphism and outcome in triple-negative breast cancer
Q41674458Association of Two Polymorphic Codons in P53 and ABCC1 Promoter with Prostate Cancer
Q35661603Association of the TP53 codon 72 polymorphism and breast cancer risk: a meta-analysis
Q28386766Combined effects of MDM2 SNP309 and TP53 R72P polymorphisms, and soy isoflavones on breast cancer risk among Chinese women in Singapore
Q43541896Epistatic interaction of Arg72Pro TP53 and -710 C/T VEGFR1 polymorphisms in breast cancer: predisposition and survival
Q42489213Estrogen receptor-alpha promoter methylation in sporadic basal-like breast cancer of Chinese women
Q39137962Evaluation of polymorphic variants in apoptotic genes and their role in susceptibility and clinical progression to systemic lupus erythematosus
Q58886632RAD51 135G>C and TP53 Arg72Pro polymorphisms and susceptibility to breast cancer in Serbian women
Q50251932TP53 codon 72 polymorphism in pigmentary phenotypes
Q37552336The Evaluation of p53 Polymorphism at Codon 72 and Association With Breast Cancer in Iran: A Systematic Review and Meta-analysis
Q82249007Tp53 codon-72 polymorphisms identify different radiation sensitivities to g2-chromosome breakage in human lymphoblast cells

Search more.